CLASS II ONGOING Device recall · Reported 22 Jan 2025 · FDA Enforcement Report

Panther Fusion GBS Assay recalled by Hologic

Hologic is recalling Panther Fusion GBS Assay, distributed in 20 states. The recall was initiated on 13 Dec 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 15420045510890, Kit Lot 715927, containing Cartridge Lot 624907, Exp. Date 2025-08-15.
Quantity recalled380

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0907-2025
FDA event ID
95948
Recalling firm
Hologic, San Diego, CA
Classification
Class II
Status
Ongoing
Recall initiated
13 Dec 2024
FDA classified
14 Jan 2025
Reported
22 Jan 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

13 Dec 2024Recall initiated by company
14 Jan 2025Classified by FDA+32 days
22 Jan 2025Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential weak pouch seal on Panther Fusion GBS assay cartridge, causing potential for invalid or incorrect results leading to a possible delay of treatment.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Panther Fusion GBS Assay REF PRD-04484 Kit containing Panther Fusion GBS Reagent Cartridge IVD.

Where it was distributed

AR, CA, CT, FL, IN, KS, LA, MA, ME, MI, NC, NJ, NV, NY, PR, TX, UT, VT, WA, WV, and Canada.

ArkansasCaliforniaConnecticutFloridaIndianaKansasLouisianaMassachusettsMaineMichiganNorth CarolinaNew JerseyNevadaNew YorkPuerto RicoTexasUtahVermontWashingtonWest Virginia

Questions about this recall

Why was it recalled?

Potential weak pouch seal on Panther Fusion GBS assay cartridge, causing potential for invalid or incorrect results leading to a possible delay of treatment.

Which lots are affected?

UDI-DI: 15420045510890, Kit Lot 715927, containing Cartridge Lot 624907, Exp. Date 2025-08-15.

Where was it sold?

AR, CA, CT, FL, IN, KS, LA, MA, ME, MI, NC, NJ, NV, NY, PR, TX, UT, VT, WA, WV, and Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Hologic

All 48

Other Test Kits & Diagnostics recalls

All 2,663